Change Font Size:

It follows that an institution devoted to the advancement of methods to diagnose and treat retinal disease will develop original milestone achievements in fulfilling its mission.  NRI is certainly no exception especially in the field of technology where it enjoys an international reputation for creating procedures that have been adopted by retina practitioners the world over.

Dr. Bert Glaser, who made innovation a key ingredient of the NRI mission at its founding in 1989, has himself been at the forefront of new discoveries that have contributed to saving the vision of thousands who might have been destined to a life of blindness. A uniquely innovative approach to the surgery needed to repair macular holes was developed by Dr. Glaser and is practiced today by retina surgeons throughout the world. He is also the inventor of the “flexible surgical rake”, which allows surgeons to more precisely target and reach the injured or diseased portion of the retina.

While photographic imaging has long been a part of diagnosing retinal disorders, it was NRI that pioneered the use of Dynamic Video ICG Angiography which has markedly advanced the diagnostic science and led to faster and more effective treatment.  The equipment at NRI to perform this “in motion” imaging can be found in few other places in the world.

Totally exclusive to the National Retina Institute is the technology developed by Dr. Glaser and the staff, to read the microbiotic markers within the eye itself to determine
more effective treatment for macular degeneration and diabetic retinopathy.  According to Dr. Glaser, the work in progress can possibly “change the way ophthalmology is practiced and eye diseases are managed throughout the world”.  Today, this technology within the institute’s Center for Ocular Proteomics is being closely watched as a potential breakthrough in relieving the devastating symptoms of diseases once thought to be incurable.